In addition, the IDH1/2 genetic alterations can be also associated with abnormal expression of platelet-derived growth factor (PDGF), leading to the abnormal activation of microglia and promoting the tumor cell’s invasiveness [17]. The gene discussed is IDH1; the disease is neoplasm.